VANCOUVER, BC / ACCESSWIRE / December 19, 2019 / Experion Holdings Ltd. (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to report and update further to past news releases involving the litigation launched by Stephen Serenas and Pacific Executive Capital Corp. (the "Plaintiffs') against Experion, its wholly-owned subsidiary Experion Biotechnologies Inc. ("Biotechnologies"), and others.
By means of a comprehensive settlement agreement reached between the Plaintiffs and Experion (including Biotechnologies), all of the Plaintiffs claims in the litigation against Experion and Biotechnologies Inc. have been fully settled and resolved.
About Experion Holdings Ltd.
Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.
Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Adult-use, Wellness and Therapeutic, and Medical products.
Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol "EXPFF" and on the Frankfurt Stock Exchange under the symbol "MB31"
For further information, please visit the Company's website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations, Phone: (604) 340-3621, Email: IR@experionwellness.com,
Disclosure
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.
SOURCE: Experion Holdings Ltd.
View source version on accesswire.com:
https://www.accesswire.com/570832/Serenas-Legal-Claims-Fully-Resolved-Against-Experion-Holdings-Ltd-and-Experion-Biotechnologies-Inc
